Gossamer Bio Inc — Cash Flow (NASDAQ:GOSS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -176.36 M-188.89 M-187.03 M-159.16 M-3.47 M-171.27 M -171.27 M Cash from investing activities 215.34 M-117.43 M-1.03 M-110.97 M29.02 M156.36 M 156.36 M Cash from financing activities 312.54 M3.33 M117.09 M190.15 M-11.49 M6.42 M 6.42 M Free cash flow -177.86 M-190.44 M-187.44 M-159.16 M-3.47 M-171.34 M -171.34 M

Haberler

Cantor Fitzgerald, deneme başarısızlığı sonrası Gossamer Bio hissesinin notunu düşürdü

Bracing for Stagflation? These 2 Stocks Offer Mouth-Watering Upside - TipRanks.com

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gossamer Bio kazancı $0,02 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - BrainsWay (NASDAQ:BWAY), Definitive Healthcare (NASDAQ:DH)

Alibaba Earnings, Jobs Data

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Here's Why Gossamer Bio (GOSS) Is a Great 'Buy the Bottom' Stock Now

Gossamer Bio (GOSS) Loses 85% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com